Treating hypercholesterinemia in a patient with maternally inherited diabetes and deafness (MIDD) by the proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor alirocumab
Crossref DOI link: https://doi.org/10.1007/s00592-021-01776-w
Published Online: 2021-08-09
Published Print: 2021-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Schultes, Bernd http://orcid.org/0000-0002-5301-1163
Ernst, Barbara
Schmid, Sebastian M.
Text and Data Mining valid from 2021-08-09
Version of Record valid from 2021-08-09
Article History
Received: 1 June 2021
Accepted: 26 July 2021
First Online: 9 August 2021
Declarations
:
: The authors declare that they have no conflict of interest.